ADM

BIOLOGICAL3 trials

Sponsors

West China Hospital, Italian Sarcoma Group, The University of Texas Health Science Center, Houston

Conditions

Dental ImplantEwing's Sarcoma (ES)Immediate Dental ImplantParotid TumorSoft Tissue Augmentation

Phase 2

Protocol for the Treatment of Metastatic Ewing Sarcoma

CompletedNCT02727387

Italian Sarcoma GroupEwing's Sarcoma (ES)

Start: 2009-06-01End: 2022-04-29Updated: 2022-09-19

Phase 3

The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome

CompletedNCT01414790

West China HospitalParotid Tumor

Start: 2004-01-31End: 2011-01-31Updated: 2011-08-11

Phase 4

Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation

CompletedNCT02864862

The University of Texas Health Science Center, HoustonDental Implant, Immediate Dental Implant, Soft Tissue Augmentation

Start: 2016-10-31End: 2021-11-22Updated: 2022-12-16

Related Papers

Volumetric buccal bone alterations at immediate implant sites with or without soft tissue augmentation: A 6‐month assessment

Journal of Periodontology2025-08-10

Maintenance therapy with oral cyclophosphamide plus celecoxib in patients with metastatic Ewing sarcoma: Results of the Italian Sarcoma Group/AIEOP EW-2 study.

Journal of Clinical Oncology2020-05-205 citations

Activity of front-line window therapy with temozolomide plus irinotecan in patients with primary multifocal Ewing sarcoma: ISG/AIEOP EW-2 protocol.

Journal of Clinical Oncology2020-05-20